Peng Li

1 month ago | arxiv.org | Ziyue Wang |Can Zhang |Peng Li |Yang Liu

arXivLabs is a framework that allows collaborators to develop and share new arXiv features directly on our website. Both individuals and organizations that work with arXivLabs have embraced and accepted our values of openness, community, excellence, and user data privacy. arXiv is committed to these values and only works with partners that adhere to them. Have an idea for a project that will add value for arXiv's community? Learn more about arXivLabs.

1 month ago | mdpi.com | Yuxiang Yan |Xiaohuang Liu |Tao Lin |Peng Li

All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.

Jan 17, 2025 | aces.onlinelibrary.wiley.com | Qian Zhou |Yu Jia Zhu |Peng Li |Wei-Hui Fang

Supporting Information As a service to our authors and readers, this journal provides supporting information supplied by the authors. Such materials are peer reviewed and may be re-organized for online delivery, but are not copy-edited or typeset. Technical support issues arising from supporting information (other than missing files) should be addressed to the authors.

Jan 10, 2025 | science.org | Rama K. Gurram |Cody Elkins |Marita Bosticardo |Peng Li

Editor’s summaryThe type I cytokine thymic stromal lymphopoietin (TSLP) is well known for its roles in regulating type 2 immunity and promoting allergic responses. Gurram et al. examined how TSLP acts directly on regulatory T cells (Tregs), which affects both phenotype and function. They observed that deletion of the TSLP receptor (TSLPR) from all T cells resulted in diminished type 2 responses after ovalbumin (OVA)–induced airway challenge.

Dec 2, 2024 | mdpi.com | Peng Li |Min Zhou |Xian Lin |Liangsong Zhou

All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.